{"nct_id":"NCT01992536","title":"Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03 (NCT01272180)","status":"COMPLETED","status_verified_date":"2016-08","start_date":"2013-12","start_date_type":null,"primary_completion_date":"2014-05","primary_completion_date_type":"ACTUAL","completion_date":"2015-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}